Postpartum high blood pressure: which medicine works better after delivery
Official title: Postpartum Evaluation of Antihypertensive Cessation and Efficacy (PEACE): A Randomized Controlled Trial Comparing Oral Labetalol and Oral Extended-Release Nifedipine for Managing Postpartum Hypertension
Run by University of California, Los Angeles · NCT06915792 · Data updated 2026-11-12
This trial tests whether extended-release nifedipine works better than labetalol to control blood pressure after giving birth.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 64 Years |
| Sex | Women only |
| Enrollment | 110 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | July 31, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT06915792 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Postpartum adults (≥18) with hypertensive disorders of pregnancy who delivered at UCLA and require oral antihypertensive therapy postpartum.
✕Probably not a fit
Patients with allergies to either study medication or significant comorbidities may not benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial assigns 110 postpartum participants with hypertensive disorders of pregnancy to receive either labetalol or extended-release nifedipine. The goal is to see which medication better maintains blood pressure control beyond six weeks postpartum. Primary outcome is continued antihypertensive use beyond 6 weeks postpartum; secondary outcomes include readmissions, side effects, and need to switch or add another antihypertensive. Remote blood pressure monitoring is used to evaluate effectiveness. The study is conducted at UCLA with participants who delivered at the same institution.
Why it matters
Potential benefit: If successful, the better-performing medication could simplify postpartum blood pressure management and reduce readmissions.
How similar studies have gone: Previous research compares labetalol and nifedipine for postpartum hypertension, but direct head-to-head randomized data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: Age ≥18 years Delivery at study institution at ≥28 weeks gestation Postpartum SBP \> 150 and/or DBP \> 100 OR 2 or more SBP \> 140 and/or DBP \> 90 within a 24-hour period Require initiation of an oral antihypertensive medication during postpartum hospital stay or within 7 days of discharge Treating obstetric team amenable to starting either study medication Exclusion criteria: Treated with oral antihypertensive medications prior to delivery Known allergies or contraindications to nifedipine or labetalol History of moderate persistent to severe asthma, chronic obstructive pulmonary disease, heart failure, or greater than first-degree atrioventricular heart block Unable to provide written informed consent in English
Where it's running
-
UCLA Ronald Reagan
Los Angeles, California, United States Recruiting
Study contacts
- Study coordinator: Tina A Nguyen, MD
- Email: tinaanguyen@mednet.ucla.edu
- Phone: 310-794-7274
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observational study on postpartum hypertension
This study looks at how high blood pressure after giving birth affects women's heart and kidney health over time and tries to find out what factors might increase their risk.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Protein supplements with or without spices to protect muscle for people on GLP-1 weight loss meds
This pilot test checks whether daily whey protein, with or without mixed spices, helps preserve muscle mass and strength in adults using GLP-1 weight-loss medicines.
-
Diet Quality Matters: A Nutrition Education Program for Los Angeles Food Rx Participants
A community-based program will test whether tailored nutrition education and cooking sessions can help low-income adults in LA improve diet quality and reduce cardiometabolic risk.
-
Diet quality in older adults and how two dietary tools compare
This study tests two diet-quality questionnaires in adults 60 and older who use LA Food Rx produce programs to see which better reflects their eating and BMI.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.